Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

WeMind appoints new CEO

September 22, 2026

TTEC Launches New Automotive Customer Experience Programme in Cairo

September 22, 2026

Dialybrid secures €15 million series A round and announces successful first-in-human implant of novel Silkothane® Arteriovenous Graft for vascular access in hemodialysis

September 22, 2026

Award-Winning Innovation: How ARGUS Multi-Ohm Cartridge Brings Real Magic to Vaping

September 22, 2026

AppSec Enterprise Spend to Approach $13 Billion Globally by 2031, as Market Leaders Revealed in New Competitor Leaderboard

September 22, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » TMCI Investors with Large Losses Should Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action Lawsuit
Press Release

TMCI Investors with Large Losses Should Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action Lawsuit

By News RoomMay 23, 20252 Mins Read
TMCI Investors with Large Losses Should Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action Lawsuit
Share
Facebook Twitter LinkedIn Pinterest Email

SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) —

Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Treace Medical Concepts, Inc. (NASDAQ: TMCI) securities between May 8, 2023 and May 7, 2024. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Treace Medical Concepts, Inc. (TMCI) Misled Investors Regarding Demand for its Primary Product

According to the complaint, during the class period, defendants failed to disclose that (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System, and (2) as a result, Treace Medical’s revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function). Plaintiff alleges that when the truth was revealed, the price of Treace Medical’s stock fell nearly 63%, to close at $4.17 per share on May 8, 2024.

What Now: You may be eligible to participate in the class action against Treace Medical Concepts, Inc. Shareholders who want to serve as lead plaintiff for the class must file their papers with the court by June 10, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.  

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against Treace Medical Concepts, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a856d076-20b2-480b-84ce-d3e6ee3a1e79

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

WeMind appoints new CEO

TTEC Launches New Automotive Customer Experience Programme in Cairo

Dialybrid secures €15 million series A round and announces successful first-in-human implant of novel Silkothane® Arteriovenous Graft for vascular access in hemodialysis

Award-Winning Innovation: How ARGUS Multi-Ohm Cartridge Brings Real Magic to Vaping

AppSec Enterprise Spend to Approach $13 Billion Globally by 2031, as Market Leaders Revealed in New Competitor Leaderboard

China Telecom AI Officially Releases Xing4.0-29B Agentic Large Model for Single-GPU Deployment

Lake Energy Launches Renewable Energy RWAs Through Blockchain-Based Platform

TradersYard Shifts Focus to Futures Trading

WUBEN Announces 2026 Long-Range Flashlight Lineup

Editors Picks

TTEC Launches New Automotive Customer Experience Programme in Cairo

September 22, 2026

Dialybrid secures €15 million series A round and announces successful first-in-human implant of novel Silkothane® Arteriovenous Graft for vascular access in hemodialysis

September 22, 2026

Award-Winning Innovation: How ARGUS Multi-Ohm Cartridge Brings Real Magic to Vaping

September 22, 2026

AppSec Enterprise Spend to Approach $13 Billion Globally by 2031, as Market Leaders Revealed in New Competitor Leaderboard

September 22, 2026

Latest News

China Telecom AI Officially Releases Xing4.0-29B Agentic Large Model for Single-GPU Deployment

September 22, 2026

Lake Energy Launches Renewable Energy RWAs Through Blockchain-Based Platform

September 22, 2026

TradersYard Shifts Focus to Futures Trading

September 22, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version